Are you curious about landing an investment for your company that’s building in the life sciences?

Join this panel with The Slater Technology Fund as they discuss the investment landscape for life sciences in Rhode Island.

Panelists will include:

  • Thorne Sparkman, Managing Director, The Slater Technology Fund
  • Dan Gilman, CEO, RxVantage
  • Isaac Stoner, CEO, Octagon Therapeutics
  • Frank Mennitti, Founder, MindImmune

These entrepreneurs have succeeded in raising capital from a variety of sources including; Angel investors, traditional venture capitalists, corporate venture capitalists, cause-related funds, regional venture capitalists, and corporate partnering agreements

Created in partnership with Rhode Island Bio

November 17, 2022